MedWellAI MWAI
OTC MWAI
$0.30 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

MedWellAI (MWAI) Research & Development (2015 - 2025)

MedWellAI's (MWAI) quarterly Research & Development came in at $250.0 in Q4 2025, down 98.64% quarter-over-quarter from $18324.0 in Q3 2025.

Analysis

MedWellAI (MWAI) Research & Development (2015 - 2025) Analysis & Trends

MedWellAI (MWAI) has reported Research & Development for 4 consecutive years, with $250.0 the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Research & Development changed N/A year-over-year to $250.0 in Q4 2025; TTM through Dec 2025 was $18574.0, a 11.12% decrease from a year earlier, with the FY2025 full-year figure at $65030.0, changed N/A from the prior year.
  • Research & Development was $250.0 for Q4 2025 at MedWellAI, down from $18324.0 in the prior quarter.
  • Over five years, Research & Development peaked at $18324.0 in Q3 2025 and troughed at $250.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Mckesson 105.79 Bn 103.19 Bn 3.69 Bn -
2 Cencora 63.13 Bn 60.51 Bn 3.61 Bn -
3 Cardinal Health 57.48 Bn 52.78 Bn 2.56 Bn -
4 Henry Schein 10.05 Bn 10.80 Bn 1.10 Bn -
5 ZeroStack 42.83 Mn 41.14 Mn 1.62 Mn -
6 111 30.11 Mn 113.01 Mn 18.18 Mn -8.41 Mn
7 Ridgetech 5.33 Mn -12.68 Mn - -
8 Guardian Pharmacy Services 5.16 Mn -72.61 Mn 80.04 Mn -
9 MedWellAI 2.27 Mn 2.28 Mn - -
10 DataMeds AI 2.20 Mn 2.15 Mn 170,221.00 960,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 250.00
Sep 30, 2025 18,324.00
Jun 30, 2017 20,898.00
Dec 31, 2016 738.00
Jun 30, 2016 894.00
Mar 31, 2016 13,942.00
Dec 31, 2015 2,021.00
Sep 30, 2015 3,340.00
Jun 30, 2015 10,287.00